Evidence map›Paper›PMID 31164776›Full record

ArticleNature chemical biology2019

Author Correction: Mitochondrial metabolism promotes adaptation to proteotoxic stress.

Peter Tsvetkov, Alexandre Detappe, Kai Cai, Heather R Keys, Zarina Brune, Weiwen Ying, Prathapan Thiru, Mairead Reidy, Guillaume Kugener, Jordan Rossen and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Enzalutamide Sensitizes Castration-Resistant Prostate Cancer to Copper-Mediated Cell Death.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Peter TsvetkovBroad Institute of Harvard and MIT, Cambridge, MA, USA. ptsvetko@broadinstitute.org.ORCID http://orcid.org/0000-0002-7577-2342
Alexandre DetappeDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9364-1621
Kai CaiBiochemistry Department, University of Wisconsin-Madison, Madison, WI, USA.
Heather R KeysWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1371-2288
Zarina BruneWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Weiwen YingOnTarget Pharmaceutical Consulting LLC, Lexington, MA, USA.
Prathapan ThiruWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Mairead ReidyDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Guillaume KugenerBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Jordan RossenBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Mustafa KocakBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Nora KoryWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Aviad TsherniakBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3797-1877
Sandro SantagataDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7528-9668
Luke WhitesellWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Irene M GhobrialDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
John L MarkleyBiochemistry Department, University of Wisconsin-Madison, Madison, WI, USA.
Susan LindquistWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Todd R GolubBroad Institute of Harvard and MIT, Cambridge, MA, USA. golub@broadinstitute.org.ORCID http://orcid.org/0000-0003-0113-2403

Funding

TR&D 3: TECHNOLOGY DEVELOPMENT FOR NMR STUDIES OF SMALL MOLECULES (METABOLOMICS, NATURAL PRODUCTS, METABOLITE-PROTEIN INTERACTIONS) pp.537-585 P41GM103399 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2012 to 2019
$9.4M
Investigating the HSF1 Cancer NetworkR01CA194005 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI SANTAGATA, SANDRO · 2016 to 2020
$2.0M
Heat Shock Directed Drug Discovery For The Treatment Of GliomasK08NS064168 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SANTAGATA, SANDRO · 2008 to 2012
$900k
Biogenesis of human mitochondrial iron-sulfur proteinsR01GM127666 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2019 to 2020
$719k
NCI NIH HHS R01 CA194005NIGMS NIH HHS P41 GM103399NIGMS NIH HHS R01 GM127666NINDS NIH HHS K08 NS064168
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31164776
PMCPMC8189136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.